Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?



Rating:

Share or cite this content

Citations should be made in the following way:
Arnaud Scherpereel (Lille, France). Rationale and targets of immunotherapy in thoracic malignancies. International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?

Member's Comments

No comment yet.

Related content which might interest you: How to select good candidates for immunotherapy against thoracic malignancies Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Immunotherapy: a new standard of care in thoracic malignancies? Source: Eur Respir J, 51 (2) 1702072; 10.1183/13993003.02072-2017 Year: 2018 Combination immunotherapy in mesothelioma: managing expectations and new toxicities Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Chemoprevention and treatment of thoracic malignancies through nutritional agents: an update on pre-clinical studies Source: Annual Congress 2010 - Nutrition and cancer Year: 2010 Optimisation of chemotherapy in the era of immunotherapy Source: Eur Respir J, 52 (4) 1801698; 10.1183/13993003.01698-2018 Year: 2018 Concomitant radiotherapy and targeted therapies Source: International Congress 2019 – New perspectives in thoracic surgical oncology Year: 2019 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Multimodality lung cancer therapy – nonsurgical complications Source: Annual Congress 2008 - High-risk patients for major lung cancer surgery Year: 2008 Rational approaches to pleural malignancies Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Translational therapeutics in pleural malignancies Source: ERS Skills course - Medical thoracoscopy Year: 2017 Pitfalls for diagnosing malignancies in the chest in times of individualized therapy Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 Other malignancies: prevention and treatment Source: School Course 2012 - Lung Transplantation Year: 2012 Current place and future of immunotherapy in lung cancer Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016 Successful targeted therapy of advanced lung cancer Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session Year: 2013 Potential of regulatory T-cell-based therapies in the management of severe COVID-19 Source: Eur Respir J, 56 (3) 2002182; 10.1183/13993003.02182-2020 Year: 2020 Are biphosphonates efficient in the adjuvant treatment of lung cancer? Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006